Categories : Oncology
Product Packaging : 1 Vial
Product Composition : 150 mg
Send MessageFosaprepitant Dimeglumine Injection is an antiemetic medication used for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with cancer treatment. It is a prodrug of aprepitant and works by blocking neurokinin-1 (NK1) receptors in the brain, helping reduce nausea and vomiting caused by highly emetogenic chemotherapy. Genliva Wellness LLP is a trusted Fosaprepitant Dimeglumine Injection Manufacturer in India offering high-quality oncology supportive care formulations for domestic and international pharmaceutical markets.
This injectable formulation is commonly administered before chemotherapy sessions to improve patient comfort and treatment compliance. As a reliable Fosaprepitant Dimeglumine Injection Exporter from India, Genliva Wellness LLP supplies quality-assured oncology supportive care products to healthcare institutions and pharmaceutical distributors worldwide.
Fosaprepitant plays a crucial role in modern cancer care by helping patients better tolerate chemotherapy and reducing the risk of severe treatment-related nausea and vomiting.
Fosaprepitant Dimeglumine Injection is formulated to provide effective prevention of chemotherapy-induced nausea and vomiting.
Fosaprepitant Dimeglumine Injection is used as part of antiemetic regimens for cancer patients undergoing chemotherapy.
Fosaprepitant Dimeglumine Injection helps improve patient comfort and treatment adherence during cancer therapy.
